Nick Damiano
Founder of Andromeda Surgical
San Francisco, California
Overview
Work Experience
CEO & Co-Founder
2023 - Current
Autonomous surgical robots with initial focus on urology YC S23
Andromeda Surgical is a developer of autonomous robots intended to make surgery more consistent, error-free, and efficient.
Venture Partner
2017
Y Combinator alumni venture fund Most active seed investor in the world as per Pitchbook
Founder & Advisor
2022 - 2023
CEO & Founder
2014 - 2022
Co-invented novel minimally invasive treatment for urinary obstruction related to BPH (enlarged prostate) Led company from concept through large randomized studies & market readiness Product has successfully treated > 300 patients in six countries Raised > $60M in venture, angel, debt, and grant funding Hired and led elite team of 28 FTEs First medtech company funded by Y Combinator (YC W15)
Zenflow is a medical company that gives new hope to men suffering from BPH symptoms.
Raised $80,068,844.00 from Invus Opportunities, Cook Medical, MedTech Venture Partners and F-Prime Capital.
Chief Strategy Officer
2022 - 2023
A new & more powerful adult pluripotent stem cell platform for difficult-to-treat diseases
NOVEL STEM CELL TECHNOLOGY TARGETING UNMET MEDICAL NEEDS
Raised $4,300,000.00 from Beyond Ventures, Magic Capital, Oriza Ventures, Magic Capital, StartX (Stanford-StartX Fund), InnoSpring Seed Fund and Magic Capital.
Co-Founder & Advisor
2014 - 2018
Company was acquired by Mendaera Formerly known as Nurep
Co-Founder & CTO
2012 - 2014
Initially known as Nurep, Inc. Mobile platform to help medical device companies remotely support surgical cases Built initial commercially launched product and closed first sale Company has raised > $100M in venture funding and launched in ~1000 hospitals
Avail is a dedicated hardware/software platform for the operating room, transforming communication between MedTech and surgical teams.
Raised $127,932,668.00 from 8VC and D1 Capital Partners.
Biodesign Fellow Externship
2014 - 2014
Advised India-based medtech company on global commercialization strategy
Biodesign Innovation Fellow
2013 - 2014
Each year an international search brings a group of fellows to Biodesign with the talent and skillset to spark the creative process and innovate.
Entrepreneur
2013 - 2013
Blueprint Health is a Charter Member of the Global Accelerator Network, which was started by TechStars
Blueprint Health is a mentorship-driven startup accelerator program in NYC, supporting entrepreneurs.
Research Engineer
2008 - 2012
Developed key algorithms for world's first fully functional leadless pacemaker ASX: EBR
EBR Systems is a provider of wireless cardiac pacing system for millions of patients suffering from cardiac rhythm diseases.
Raised $199,857,026.00 from M. H. Carnegie & Co., Brandon Capital, Emergent Medical Partners, Split Rock Partners, Ascension Ventures, M. H. Carnegie & Co., Brandon Capital, Thomas Fogarty, Ascension Ventures and Split Rock Partners.
Education
Biodesign Innovation Fellow
2013 - 2014
M.S.
2004 - 2006
B.S.
2001 - 2006